|

This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.

RECRUITINGN/ASponsored by King Faisal Specialist Hospital & Research Center
Actively Recruiting
PhaseN/A
SponsorKing Faisal Specialist Hospital & Research Center
Started2025-11-12
Est. completion2026-11-12
Eligibility
Age6 Years – 14 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07788534

Summary

This study aims to evaluate whether incorporating FeNO monitoring into routine pediatric asthma care improves clinical outcomes relative to a historical cohort managed without FeNO

Eligibility

Age: 6 Years – 14 YearsHealthy volunteers accepted
Inclusion Criteria:

* Children aged 6 to 14 years with a physician-diagnosed asthma.

  * Minimum of three months' follow-up at the pediatric respiratory clinic.
  * Availability of Asthma Control Test (ACT/C-ACT) scores and clinical data

Exclusion Criteria:

* Presence of other chronic pulmonary diseases (e.g., cystic fibrosis).

  * Recent respiratory infections within four weeks prior to enrollment.
  * Current treatment with biologic agents affecting asthma inflammation.

Conditions2

AsthmaAsthma Childhood

Browse More Trials

Asthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.